Loading...
ACADIA Pharmaceuticals Inc.
ACAD•NASDAQ
Healthcare
Biotechnology
$23.25
$0.20(0.87%)
ACADIA Pharmaceuticals Inc. (ACAD) Financial Performance & Income Statement Overview
Review ACADIA Pharmaceuticals Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
31.85%
↑ 31.85%
Operating Income Growth
414.52%
↑ 414.52%
Net Income Growth
469.50%
↑ 469.50%
Operating Cash Flow Growth
844.31%
↑ 844.31%
Operating Margin
23.58%
↑ 23.58%
Gross Margin
92.04%
↑ 92.04%
Net Profit Margin
22.97%
↑ 22.97%
ROE
35.32%
↑ 35.32%
ROIC
28.30%
↑ 28.30%
ACADIA Pharmaceuticals Inc. (ACAD) Income Statement & Financial Overview
Review ACADIA Pharmaceuticals Inc.'s (ACAD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $259.60M | $250.40M | $241.96M | $205.83M |
| Cost of Revenue | $21.80M | $18.86M | $18.23M | $22.95M |
| Gross Profit | $237.80M | $231.54M | $223.73M | $182.88M |
| Gross Profit Ratio | $0.92 | $0.92 | $0.92 | $0.89 |
| R&D Expenses | $100.73M | $66.61M | $76.23M | $59.68M |
| SG&A Expenses | $130.08M | $133.29M | $117.06M | $107.99M |
| Operating Expenses | $84.30M | $199.90M | $193.30M | $167.67M |
| Total Costs & Expenses | $106.10M | $218.76M | $211.53M | $190.62M |
| Interest Income | $7.007M | $6.59M | $6.36M | $5.51M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $5.21M | $0.00 | $2.57M | $5.53M |
| EBITDA | $12.20M | $31.64M | $33.008M | $20.74M |
| EBITDA Ratio | $0.05 | $0.13 | $0.14 | $0.10 |
| Operating Income | $153.50M | $31.64M | $30.44M | $15.21M |
| Operating Income Ratio | $0.59 | $0.13 | $0.13 | $0.07 |
| Other Income/Expenses (Net) | $7.58M | $7.16M | $6.75M | $5.79M |
| Income Before Tax | $161.09M | $38.81M | $37.18M | $21.002M |
| Income Before Tax Ratio | $0.62 | $0.15 | $0.15 | $0.10 |
| Income Tax Expense | $17.34M | $6.04M | $3.79M | $4.45M |
| Net Income | $143.74M | $32.77M | $33.39M | $16.55M |
| Net Income Ratio | $0.55 | $0.13 | $0.14 | $0.08 |
| EPS | $0.87 | $0.20 | $0.20 | $0.10 |
| Diluted EPS | $0.86 | $0.20 | $0.20 | $0.10 |
| Weighted Avg Shares Outstanding | $166.53M | $165.97M | $165.55M | $164.80M |
| Weighted Avg Shares Outstanding (Diluted) | $166.36M | $166.18M | $166.17M | $166.62M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan